We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical Receives CE Mark Approval for ReCIVA™

News   Oct 05, 2016

 
Owlstone Medical Receives CE Mark Approval for ReCIVA™
 
 
Advertisement
 

RELATED ARTICLES

What Makes Some Brain Cells Resilient Against Alzheimer's?

News

Researchers have discovered that neurons with high levels of the protein apolipoprotein E are more sensitive to degeneration, and therefore Alzheimer's disease.

READ MORE

Dementia Linked to Poor Kidney Function by Large Study

News

According to a study, older people with kidney disease have a higher risk of dementia, and the risk increases with the rate and stage of kidney function decline.

READ MORE

Enzyme That Is Critical for Kidney Health Could Help 700 Million People Worldwide

News

University of South Australia researchers have identified an enzyme that may help to curb chronic kidney disease, which affects approximately 700 million people worldwide.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE